Navigation Links
Heart Chocolate(TM) With CM-X(TM) is Loved by Chocolate Connoisseurs and Diabetics Alike

Rich, dark chocolate bar with innovative CM-X gives new meaning to diabetic


TORONTO, Oct. 23 /PRNewswire/ -- Heart Chocolate(TM) with CM-X(TM), recently launched by Innovative Life Sciences Corporation (ILS), is more than just another so-called diabetic food. Manufacturers of food for the diabetic market customarily minimize ingredients that either increase blood sugar and/or cholesterol. Many consumers are left feeling unsatisfied because although they may minimize the amount of sugar or cholesterol, most diabetic foods fail to minimize both and deliver great taste -- and are still high in calories.

Heart Chocolate with CM-X is in a class all by itself. Not only does it contain no sugar, minimal calories and great taste, but also it provides significant health benefits for diabetics and others.

"There is no real definition or standard for using the term diabetic when applied to foods. In formulating Heart Chocolate with CM-X, ILS made a great- tasting product with ingredients that actually reduce blood sugar and cholesterol," explains David Solomon, president of ILS. "That is what makes Heart Chocolate so unique."


CM-X is a highly sophisticated and natural proprietary compound of cinnamon and bitter melon extracts developed by ILS for the treatment of diabetes and related cardiovascular diseases.

"This could be the first herbal combination with the potential to have more significant effects than pharmaceutical drugs on this triumvirate of conditions, which continues to have a major impact on the health of North Americans," says Maggie Laidlaw, director of the Clinical Trial Division of Nutrasource Diagnostics Inc. and former associate director of Human Nutraceuticals at the Univeristy of Guelph.

In her soon-to-be published abstract, Laidlaw states that bitter melon and cinnamon have similar physiological effects -- they lower glucose, cholesterol and triglycerides. The mechanisms of action, however, are different providing for synergism between them and provide the following potential combined benefits:

-- reduction in blood glucose levels and increased glucose tolerance in

diabetics and people with metabolic syndrome;

-- reduction in total and LDL cholesterol and triglycerides, and increase

in HDL cholesterol in people with dyslipidemia, including people with

metabolic syndrome;

-- reduction in obesity, suppressing appetite;

-- improved antioxidant capacity, with the potential to protect diabetics

against free radical damage, and to reduce oxidized LDL cholesterol


Heart Chocolate and Pusateri's

Heart Chocolate(TM) was launched at Pusateri's during the 2007 Toronto International Film Festival and sales have more than exceeded expectations selling over 600 bars each weekend.

"As specialty retailers with two locations in the premier residential areas of Toronto, we are constantly searching for the finest innovative products the world has to offer," says John Mastroianni, Pusateri's. "Heart Chocolate has been one of the quickest selling new products our shops have introduced. More importantly, this healthy chocolate gives our customers a reason to eat chocolate and feel great about it!"

About Innovative Life Sciences Corporation (ILS)

Innovative Life Sciences Corporation, headquartered in Toronto, Ontario, and its strategic partners consist of various professionals -- each with extensive experience in diverse disciplines including law, marketing, product development, food manufacturing, research, testing, medicine and science. Together, the team brings an unparalleled level of scientific knowledge and business experience. In addition to Smart Chocolate with CM-X, Innovative Life Sciences has developed several other food products that contain the healing properties of CM-X.

SOURCE Innovative Life Sciences Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Epileptic Seizures Can Be Duec to Heart Problem
3. Bypass Heart Surgery Performed Without General Anesthesia
4. New CPR Guidelines issued by Heart Association
5. White Cells Count Can Predict Heart Attack Death Risk
6. Vitamins-The answer to Heart Disease?
7. Fight Heart disease and Pain with Meditation
8. Heart disease in the newborn is related to maternal malnutrition
9. New drug to treat Heart Attack and damaged tissue
10. Starvation in pregnant women can cause heart disease to their children
11. Individuals with sleep related breathing disorders more prone to heart disease
Post Your Comments:
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
(Date:11/26/2015)... San Antonio, TX (PRWEB) , ... November 26, 2015 , ... ... accomplishment! On November 19, 2015, our surgeons performed their 6,000th free flap breast ... Ledoux , “We wake up every day excited to rebuild lives and it’s an ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film ... trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 ... with any font, giving users limitless opportunities to stylize and create designs quickly ...
(Date:11/26/2015)... ... ... Inc., developer and distributor of the world-class Asterisk based contact center software Q-Suite, announces ... new Q-Suite 6 platform is based on the latest Java Enterprise standards. By conforming ... of software for many key components of the suite. Much of the suite runs ...
(Date:11/25/2015)... ... November 25, 2015 , ... As part ... For Empowerment ™ attracts volunteers together who want to combine talents and resources ... key stakeholders in the process. The non-profit launched its first major fundraiser on ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 ... the  "2016 Future Horizons and Growth ... Monitoring (TDM) Market: Supplier Shares, Country ...  report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... , November 26, 2015 ... addition of the "Radioimmunoassay Market by ... (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), ... Global Forecast to 2020" report to ... has announced the addition of the ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
Breaking Medicine Technology: